Atrial Fibrillation Perspective

 
 

  • Five New Neurology Studies: Possible Breakthroughs, Some Failures   Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.
  • May 6 2022 This Week in Cardiology   HRS meeting presentations: conduction system pacing, AF in the ED, a possible new treatment for vagal bradycardia, and women in EP are the topics John Mandrola, MD, discusses in this week’s podcast.
  • HRS 2022 Read clinically focused news coverage of key developments from HRS 2022
  • Apr 22 2022 This Week in Cardiology   Critiques of last week’s comments on VT ablation and a review of EHRA presentations, including new ways to ablate atrial myocardium and pace the ventricle, are discussed by John Mandrola, MD, in this week’s podcast.
  • Benefit of SubQ Arrhythmia Monitoring Post-MI May Hinge on Risk   Drs Jagmeet Singh and Christian Jøns discuss results of the BIO|GUARD-MI study that used an insertable cardiac monitor to track arrhythmias in post-MI patients to see if treating them improved outcomes.
  • The More You Know Your Patient, the Better Care You Can Give As visit times are compressed, it's hard to spend extra time with our patients. But can we afford not to?
  • ACC 2022 Mavacamten in HCM: Reasons for Optimism and Caution The novel drug helped patients avoid septal reduction therapy in the short term and approval looks likely, but more details and longer-term safety data will be needed before broader use, writes John Mandrola, MD.
  • HFpEF: New Treatments Provide 'Hope'   Drs Clyde Yancy and Ravi Patel discuss contemporary treatment approaches for heart failure with preserved ejection fraction.
  • Mar 25 2022 This Week in Cardiology   AF ablation vs rate control in HF, TAVI vs SAVR, atherosclerosis, and surrogate endpoints in observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.
  • ACC 2022 Read clinically focused news coverage of key developments from ACC 2022
  • COVID-19 and the Heart: Is Cardiology Ready?   Robert Harrington, MD, interviews Ziyad Al-Aly, MD, about his recent paper in Nature Medicine focused on the long-term cardiovascular effects of COVID-19.
  • Mar 11 2022 This Week in Cardiology   AF screening, CTA, stroke prevention and broken observational studies, and medical writing are the topics John Mandrola, MD discusses in this week’s podcast.
  • Antiseizure Meds and Cardiovascular Risk   Dr Andrew Wilner speaks with researcher Dr Colin Josephson about how big data is revealing the ways that certain epilepsy treatments elevate risks.
  • Feb 25 2022 This Week in Cardiology   FDA approval of CardioMEMS, statins, VT storm, and fish oil and AF are the topics covered by John Mandrola, MD, in this week’s podcast.
  • What Are the Determinants of Cardiovascular Disease Risk Equivalents Among Adults with Diabetes Mellitus? For patients with diabetes without prior CVD, there is higher associated relative CVD risk among women, patients of younger age, White race, elevated CRP or triglyceride levels, or decreased kidney function.
  • Feb 4 2022 This Week in Cardiology   Interatrial shunt therapy, the power of the RCT, chronic stress, anxiety and cardiometabolic risk, and TAVR, are the topics covered by John Mandrola, MD, in this week’s podcast.
  • Jan 28 2022 This Week in Cardiology   AF Screening, alcohol, sports-related sudden death, non-MD-led healthcare, and CPR are the topics John Mandrola, MD, discusses in this week’s podcast.
  • The Must-Read Acute Care Medicine Articles From 2021 Dr Amal Mattu discusses his top picks for the most important acute care literature of the past year. What are your picks?
  • ECG Challenge: Fast Heartbeat With a Pacemaker During a routine physical exam, this man's heart is beating at a fast clip. What's going on with his pacemaker?
  • This Doc Still Supports NP/PA Led Care … With Caveats The rise in nurse practitioner- and physician assistant-led care will not be undone, according to this doctor who sees it as a good thing as long as training and experience are not neglected.